Abstract: Disclosed are methods of making selective estrogen receptor degraders (SERDs) of Formula (A), as well as intermediates thereof, salts thereof including a pharmaceutically acceptable salt, and pharmaceutical compositions thereof: wherein either R1 or R2 is independently Cl, F, -CF3, or -CH3, and the other is H; and R7 is H or PG.
| # | Name | Date |
|---|---|---|
| 1 | 202417056959-STATEMENT OF UNDERTAKING (FORM 3) [26-07-2024(online)].pdf | 2024-07-26 |
| 2 | 202417056959-REQUEST FOR EXAMINATION (FORM-18) [26-07-2024(online)].pdf | 2024-07-26 |
| 3 | 202417056959-PROOF OF RIGHT [26-07-2024(online)].pdf | 2024-07-26 |
| 4 | 202417056959-POWER OF AUTHORITY [26-07-2024(online)].pdf | 2024-07-26 |
| 5 | 202417056959-FORM 18 [26-07-2024(online)].pdf | 2024-07-26 |
| 6 | 202417056959-FORM 1 [26-07-2024(online)].pdf | 2024-07-26 |
| 7 | 202417056959-DRAWINGS [26-07-2024(online)].pdf | 2024-07-26 |
| 8 | 202417056959-DECLARATION OF INVENTORSHIP (FORM 5) [26-07-2024(online)].pdf | 2024-07-26 |
| 9 | 202417056959-COMPLETE SPECIFICATION [26-07-2024(online)].pdf | 2024-07-26 |
| 10 | 202417056959-Proof of Right [05-08-2024(online)].pdf | 2024-08-05 |
| 11 | 202417056959-FORM 3 [14-01-2025(online)].pdf | 2025-01-14 |
| 12 | 202417056959-FORM 3 [14-01-2025(online)]-1.pdf | 2025-01-14 |